Merck Serono to fund own R&D group at in-demand Ablynx
This article was originally published in Scrip
Executive Summary
Belgium firm Ablynx, which is having major news flow this week following a major deal with AbbVie, has now expanded its relationship with Merck Serono through a multi-year research alliance that the partners say could lead to at least four co-discovery and co-development collaborations.